Soliris®

BIOLOGICAL2 trials

Sponsors

AO GENERIUM, Assistance Publique - Hôpitaux de Paris

Conditions

Hypertensive Emergency-associated Hemolytic Uremic SyndromeMarchiafava-Micheli SyndromeParoxysmal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria

Phase 3

Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH

CompletedNCT04463056

AO GENERIUMMarchiafava-Micheli Syndrome, Paroxysmal Hemoglobinuria, Paroxysmal Nocturnal Hemoglobinuria

Start: 2017-11-29End: 2018-10-16Updated: 2021-09-01

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

RecruitingNCT05726916

Assistance Publique - Hôpitaux de ParisHypertensive Emergency-associated Hemolytic Uremic Syndrome

Start: 2023-11-09End: 2027-11-09Target: 66Updated: 2024-01-05

Related Papers

Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab

Annals of Hematology2021-08-1630 citations